Clinical outcomes of allogeneic stem cell transplantation for relapsed or refractory follicular lymphoma: a retrospective analysis by the Fukuoka Blood and Marrow Transplantation Group.Int J Hematol.(2013).
Efficacy and Safety of Aprepitant in Allogeneic Hematopoietic Stem Cell Transplantation.Pharmacotherapy.(2013).
Reduced intensity conditioning in allogeneic stem cell transplantation for AML with Down syndrome.Pediatr Blood Cancer.(2013).
Combination of bortezomib, thalidomide, and dexamethasone (VTD) as a consolidation therapy after autologous stem cell transplantation for symptomatic multiple myeloma in Japanese patients.Int J Hematol.(2014).
The ordered acquisition of Class II and Class I mutations directs formation of human t(8;21) acute myelogenous leukemia stem cell.Exp Hematol.(2014).
Treatment of adult T-cell leukemia/lymphoma with cord blood transplantation: a Japanese nationwide retrospective survey.Biol Blood Marrow Transplant.(2014).
Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups.Haematologica.(2016).
Allogeneic stem cell transplantation for acute lymphoblastic leukemia in adolescents and young adults.Biol Blood Marrow Transplant.(2019).
Outcomes of allogeneic hematopoietic stem cell transplantation for ATL with HTLV-1 antibody positive donors: Allo-HCT for ATL from HTLV-1 antibody positive donors.Biol Blood Marrow Transplant.(2019).
Prophylaxis and treatment with mycophenolate mofetil in children with graft-versus-host disease undergoing allogeneic hematopoietic stem cell transplantation: a nationwide survey in Japan.Int J Hematol.(2019).